Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-06 Sale |
2021-07-08 7:19 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $24.52 | $159,380 | 356,606 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-06 5:52 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $24.78 | $433,650 | 342,489 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-03 8:07 pm |
Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director |
17,489 | $26.28 | $459,611 | 2,232,251 (Indirect) |
View |
| 2021-06-01 Sale |
2021-06-02 4:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $26.24 | $80,151 | 224,010 (Indirect Direct) |
View |
| 2021-05-03 Sale |
2021-05-04 4:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $30.56 | $93,361 | 227,065 (Indirect Direct) |
View |
| 2021-05-03 Sale |
2021-05-04 4:06 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $30.56 | $128,352 | 362,099 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 5:15 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $28.75 | $87,828 | 230,120 (Indirect Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 5:14 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
50,000 | $28.64 | $1,432,166 | 366,299 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 5:56 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $30.48 | $93,112 | 233,175 (Indirect Direct) |
View |
| 2021-02-01 Sale |
2021-02-02 4:08 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,055 | $29.24 | $89,321 | 236,230 (Indirect Direct) |
View |
| 2021-01-08 Sale |
2021-01-11 7:54 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $28.12 | $281,200 | 274,581 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 6:48 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
3,060 | $25.29 | $77,399 | 241,785 (Indirect Direct) |
View |
| 2020-10-09 Sale |
2020-10-14 4:54 pm |
Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director |
13,000 | $28.93 | $376,090 | 2,523,075 (Indirect) |
View |
| 2020-07-10 Purchase |
2020-07-14 4:46 pm |
Akero Therapeutics Inc. | AKRO | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner |
415,000 | $36 | $14,940,000 | 5,830,203 (Direct) |
View |
| 2020-07-10 Purchase |
2020-07-14 4:45 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director 10% Owner |
415,000 | $36 | $14,940,000 | 5,830,203 (Indirect) |
View |
| 2020-07-01 Sale |
2020-07-06 7:00 pm |
Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner |
116,467 | $34.4 | $4,006,537 | 3,033,552 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-12 Option Award |
2021-07-14 4:09 pm |
N/A 2031-07-12 |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 7:19 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 356,606 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 7:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 356,606 (Direct) |
View |
| 2021-06-28 Other |
2021-06-30 4:31 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | ATP Life Science Ventures L.P. ATP III GP Ltd. 10% Owner |
5,830,203 | $0 | 5,830,203 (Direct) |
View |
Ownership |
2021-06-30 4:16 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd 10% Owner |
0 | $0 | 4,907,829 (Indirect) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:59 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:58 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:58 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:57 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:56 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:56 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-06-01 Gift |
2021-06-03 5:55 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
49,832 | $0 | 62,832 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:55 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
13,000 | $0 | 62,832 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-04 4:06 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $0 | 362,099 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-04 4:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,200 | $7.009 | 362,099 (Direct) |
View |
| 2021-04-22 Option Award |
2021-04-26 5:09 pm |
N/A 2031-04-22 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 5:14 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
50,000 | $0 | 366,299 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-05 5:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
50,000 | $7.01 | 366,299 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 7:57 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
20,000 | $0 | 618,701 (Direct) |
View |
| 2020-12-31 Gift |
2021-01-11 7:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
3,000 | $0 | 618,701 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 7:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
20,000 | $0.615 | 618,701 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 7:54 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
7,500 | $0 | 274,581 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 7:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
7,500 | $0.615 | 274,581 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 4:53 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
7,480 | $0 | 621,701 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 4:53 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
7,480 | $0.62 | 621,701 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 4:19 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,500 | $0 | 621,701 (Direct) |
View |
| 2020-12-11 Gift |
2020-12-23 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
2,550 | $0 | 621,701 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,500 | $0.62 | 621,701 (Direct) |
View |
| 2020-06-30 Option Award |
2020-12-09 8:53 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
1,245 | $17.07 | 322,425 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-09 8:53 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
77,580 | $0 | 322,425 (Direct) |
View |
| 2020-06-30 Option Award |
2020-12-09 8:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
1,245 | $17.07 | 79,850 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-09 8:52 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
77,580 | $0 | 79,850 (Direct) |
View |
| 2020-06-30 Option Award |
2020-12-09 8:50 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
1,245 | $17.07 | 242,494 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-09 8:50 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
77,580 | $0 | 242,494 (Direct) |
View |
| 2020-06-30 Option Award |
2020-12-09 8:49 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,245 | $17.07 | 321,758 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-09 8:49 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
77,580 | $0 | 321,758 (Direct) |
View |
| 2020-06-30 Option Award |
2020-12-09 8:47 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew Chief Executive Officer |
1,245 | $17.07 | 570,059 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-09 8:47 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew Chief Executive Officer |
242,500 | $0 | 570,059 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-11 7:01 pm |
N/A 2030-06-09 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-02 6:54 pm |
N/A 2030-05-31 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
13,000 | $0 | 13,000 (Direct) |
View |